Octreotide Acetate
Product Images NDC 76135-005

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 76135-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Usv North America Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Octreotide 01)

Chemical structure diagram of Octreotide Acetate, showing its peptide sequence with specified amino acids and acetate content range (x = 1.4 to 2.5).*

FDA Label Image

Octreotide 1000 (Octreotide 1000mcg mL)

Label for Octreotide Acetate Injection, 5,000 mcg per 5 mL (1,000 mcg/mL) in a 5 mL multiple dose vial. The label states it is for subcutaneous injection, indicates storage in a refrigerator at 2° to 8°C (36° to 46°F), and protection from light. Manufactured for USV North America Inc.*

FDA Label Image

Octreotide 200 (Octreotide 200mcg mL)

Label of Octreotide Acetate Injection by USV North America Inc., displaying a 5 mL multiple dose vial with a total strength of 1,000 mcg per 5 mL (200 mcg/mL). The label includes storage instructions to keep refrigerated at 2° to 8°C, protect from light, and discard within 14 days after initial use. It indicates the product is for subcutaneous injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.